Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 12,000 shares at $81.57 ($979K) on 2020-11-10, disclosed to the SEC on 2020-11-12.
Open-market sale of $979k MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.57 | 6,000 | $489K | 50.0% |
| 2 | $81.57 | 6,000 | $489K | 50.0% |
| Total | $81.57 avg | 12,000 | $979K | 100% |
| Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |
| MGLN | SELL | 2019-12-11 | $2.6M | — | Filing → |